Status:
ENROLLING_BY_INVITATION
Effectiveness of Original vs. AI-Generated Plain Language Summaries of Systematic Reviews
Lead Sponsor:
University of Split, School of Medicine
Collaborating Sponsors:
University Hospital of Split
Conditions:
Non-Metastatic Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The study explores how patients with non-metastatic breast cancer perceive and comprehend original Plain Language Summary and AI-generated Plain Language Summary (PLS) of two systematic reviews from t...
Detailed Description
Studies show that Plain Language Summaries (PLS), which are intended to improve accessibility to health information for laypeople, are lacking in terms of comprehension, readability, and user engageme...
Eligibility Criteria
Inclusion
- female patients with histologically confirmed non-metastatic breast cancer currently undergoing chemotherapy or radiotherapy:
- neoadjuvant chemotherapy (with or without immunotherapy or antiHER2 therapy),
- adjuvant chemotherapy (with or without immunotherapy or antiHER2 therapy),
- adjuvant radiotherapy (including local and locoregional radiation treatment with possible radiotherapy boost where indicated).
- patients need to be able to read and understand Croatian.
Exclusion
- female patients with metastatic breast cancer.
- female patients receiving only hormonal treatment.
Key Trial Info
Start Date :
August 14 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT07140107
Start Date
August 14 2025
End Date
February 1 2026
Last Update
August 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Oncology and Radiotherapy, University Hospital Split
Split, Croatia, 21000